Suggestions
Jeffrey Thompson
Director, Health Outcomes at Kantar Health
Professional Background
Jeffrey Thompson has cultivated a robust career in health outcomes, pharmaceutical sciences, and analytics, drawing from a solid educational foundation and practical experience. Currently, he serves as the Director of Health Outcomes at Kantar Health, where he leads initiatives aimed at improving healthcare decision-making through actionable insights and data analysis. His expertise lies in assessing the impact of health interventions and utilizing advanced data analytics to generate meaningful health outcomes that can guide policies and practices in the healthcare industry.
Before assuming his current role, Jeffrey made significant contributions to Kantar Health as the Manager of Health Outcomes, showcasing his exceptional leadership and analytical skills. He has also held influential positions at CVS Health, where he worked as an Advisor in Analytics, helping the organization enhance its analytical capabilities for better health outcome assessments. Jeffrey's versatile career also includes consulting roles where he provided insights and strategic recommendations for both Eli Lilly Co. and Thompson Labs LLC. His experience in project management and data coordination with Medpace further underscores his proficiency in the field, enabling him to navigate complex datasets and derive impactful conclusions.
Education and Achievements
Jeffrey’s academic journey is equally impressive, marked by his commitment to understanding the intricate relationship between healthcare interventions and patient outcomes. He earned his Bachelor of Science in Neuroscience from Brown University, where he laid the groundwork for his passion for neuroscience and its applications in healthcare. Following this, he pursued a Master of Science in Pharmaceutical Sciences at the University of Cincinnati, College of Pharmacy, graduating with a stellar 4.00 GPA, reflecting his dedication and capability in the pharmacological field.
Jeffrey further advanced his education by obtaining a Ph.D. in Health Outcomes from the University of Cincinnati, College of Pharmacy, where he achieved an impressive 3.88 GPA. This rigorous academic background has equipped him with the skills necessary to conduct in-depth research and analysis, solidifying his status as a thought leader in health outcomes and pharmaceutical sciences. His research focuses on evaluating healthcare interventions and patient experiences, contributing valuable insights to the field.
Notable Achievements
Throughout his career, Jeffrey has exhibited a commitment to advancing the sciences that underpin healthcare decision-making and patient outcomes. His notable achievements include leading comprehensive research projects that have influenced health policy and improved patient care practices. As a consultant for Eli Lilly Co., he played a key role in research initiatives that have contributed to developing effective treatment protocols and health interventions. His work at Thompson Labs LLC involved strategic business development and regulatory affairs, further enhancing his understanding of the operational aspects of healthcare organizations.
Jeffrey’s diverse skill set has not only allowed him to excel in various roles but also to collaborate effectively with multidisciplinary teams and stakeholders across the healthcare spectrum. His analytical acumen and strategic vision continue to position him as a valuable asset in the health outcomes domain.
In addition to his professional roles, Jeffrey’s background in neuroscience and pharmaceutical sciences empowers him to approach health outcomes research with a unique perspective that integrates scientific rigor with practical insights. His ability to translate research findings into actionable recommendations is a hallmark of his career, reflecting his deep commitment to enhancing patient health and healthcare systems.